Skip to main content
Dose-Response logoLink to Dose-Response
. 2008 Jan 17;6(4):319–332. doi: 10.2203/dose-response.06-117.Belyaeva

Modeling of Respiratory System Dysfunction Among Nuclear Workers: A Preliminary Study

ZD Belyaeva 1, SV Osovets 1, BR Scott 2, GV Zhuntova 3, ES Grigoryeva 3
PMCID: PMC2592993  PMID: 19088899

Abstract

Numerous studies have reported on cancers among Mayak Production Association (PA) nuclear workers. Other studies have reported on serious deterministic effects of large radiation doses for the same population. This study relates to deterministic effects (respiratory system dysfunction) in Mayak workers after relatively small chronic radiation doses (alpha plus gamma). Because cigarette smoke is a confounding factor, we also account for smoking effects. Here we present a new empirical mathematical model that was introduced for simultaneous assessment of radiation and cigarette-smoking-related damage to the respiratory system. The model incorporates absolute thresholds for smoking- and radiation-induced respiratory system dysfunction. As the alpha radiation dose to the lung increased from 0 to 4.36 Gy, respiratory function indices studied decreased, although remaining in the normal range. The data were consistent with the view that alpha radiation doses to the lung above a relatively small threshold (0.15 to 0.39 Gy) cause some respiratory system dysfunction. Respiratory function indices were not found to be influenced by total-body gamma radiation doses in the range 0–3.8 Gy when delivered at low rates over years. However, significant decreases in airway conductance were found to be associated with cigarette smoking. Whether the indicated cigarette smoking and alpha radiation associated dysfunction is debilitating is unclear.

Keywords: radiation, dose-response, threshold, respiratory function

INTRODUCTION

Workers at the Mayak Plutonium Production Facility (Mayak PA) were chronically exposed over years to alpha (from inhaled 239Pu) and gamma radiations as a result of their occupational setting (Khokhryakov et al. 2000a). Numerous studies have focused on dosimetry and cancer induction among the Mayak PA workers (Tokarskaya et al. 1995; Vasilenko et al. 2000; Khokhryakov et al. 2000a,b; Gilbert et al. 2001; Suslova et al. 2002; Hahn et al. 2003; Shilnikova et al. 2003; Tokarskaya et al. 2006). It is also important to study morbidity endpoints other than cancer. Since the lung is a primary deposition site for inhaled Pu aerosols, this study focuses on respiratory function abnormalities among the Mayak PA workers. The function of the respiratory system is influenced by different agents that include internal and external radiation, inhaled particles from forest and other fires, and airborne chemical toxicants (including cigarette smoke), and is influenced by age and body mass (Balmes et al. 2003; Anderson et al. 1997; Samet and Lange 1996; Higenbottam et al. 1980; Knudson et al. 1987; Lebowitz et al. 1987).

Radiation doses to pulmonary tissue in the range of 20–30 Gy induce fibrosis and radiation pneumonitis and cause respiratory system dysfunction in patients during fractionated radiotherapy treatment of lung cancer (Abratt and Morgan 2002), after total body irradiation before bone marrow transplantation (Thomas et al. 2001), and in experiments where dogs inhaled large amounts of insoluble 239PuO2 (Muggenburg et al. 1996).

High-level alpha radiation exposure of humans occurred as a result of lax radiation protection practices during the early years of operation of the Mayak PA (Koshurnikova et al. 1999; Khokhryakov et al. 2002). In some cases this led to plutonium pneumosclerosis, whose clinical characteristics and associated radiation doses are discussed in several publications (Ilyin 2005; Okladnikova et al. 2000a; Koshurnikova et al. 1973). According to published data (Okladnikova et al. 2000b), in order to induce plutonium pneumosclerosis among Mayak PA workers, the absorbed alpha radiation dose to the lung had to be about 1.4 Gy or higher. However, this low value may relate to the workers also having been exposed to gamma rays, which has not been accounted for in this threshold estimate.

Current radiation protection standards and protective equipment at nuclear industry facilities in Russia limit inhalation of significant amounts of radionuclides and external gamma-ray exposure. Persistent respiratory system dysfunction was not detected in preliminary studies of Mayak PA workers who were exposed to external gamma-rays and internal alpha radiation over years in amounts not exceeding the maximum permissible annual dose (15 cSv) (Okladnikova et al. 2000c). Preliminary finding suggests a large cumulative radiation dose threshold for inducing persistent respiratory system dysfunction in the case of chronic exposure of the adult lung at low rates over years to alpha plus gamma radiations; however, more research is needed on this topic.

The present study was conducted with the following two goals: (1) to assess the functional state of the respiratory system (bronchopulmonary components) of a group of male Mayak PA workers who were chronically exposed at low rates over years to external gamma rays and internal alpha radiation (due to inhalation of plutonium aerosols), and (2) to develop an empirical threshold-type model for quantitatively characterizing respiratory system dysfunction (based on specific respiratory system variables) as a function of radiation doses (alpha and gamma) and smoking history. The model will facilitate estimation of thresholds for inducing the deterministic effect of interest (i.e., respiratory system dysfunction).

METHODS

Only previously documented dosimetry and clinical information were used in this study. Pulmonary function measurement protocols discussed here refer to work previously carried out by Russian physicians and scientists prior to initiating the clinical study during periodical prophylactic medical examinations of Mayak PA workers. The present study was approved by the Southern Ural Institutional Review Board. The SUBI assures that it complied with U.S. Department of Energy regulations for protection of human research subjects (10 CFR 745) and the Russian Federation Law of Public Health Protection (1993). In addition, the Western Institutional Review Board, Western International Review Board granted the project in which this study was undertaken an exempt status.

Specific respiratory system function measurements were used to assess the status of the bronchopulmonary system. The respiratory system function measurements were carried out during medical examinations of 386 male Mayak PA workers over a prolonged follow-up period (from 7 to 50 y for some subjects). The workers were exposed via inhalation to 239Pu aerosols and were also exposed to sources of external gamma radiation from neutron-activation and fission-product sources in the workplace. The indicated exposures occurred over several decades and the length of exposure varied for different individuals.

Individuals with bronchopulmonary diseases, plutonium pneumosclerosis, and other diseases which could influence respiratory function indices were not included in the present study. The respiratory function measurements were carried out 2–3 times with several year intervals for a majority of the individuals (65.7 %). In individual with a long-term follow-up period the number of respiratory function measurement was 10–12 times. The intervals between measurements were 5–10 years. Age at the time of respiratory function evaluation ranged from 19 to 81 years (average 44.2 ± 0.32 y). The time from starting work with sources of ionizing radiation until respiratory function evaluation ranged from 1 to 50 years (average 20.9 ± 0.31 y).

The following variables of the respiratory system function were analyzed: vital capacity (VC), carbon monoxide diffusing capacity (DCO), airway conductance including forced expiratory flow in one second (FEV1), and forced expiratory flow for 25%, 50%, or 75% of forced vital capacity (FEF25, FEF50, FEF75). Relative values were calculated as a ratio of the measured value and the predicted value, and were expressed as a percent (%) of the predicted value (Koo et al. 2000; Mustajbegovic et al. 2003). The predicted value was calculated as a function of age, height and body mass index (Knudson et al. 1987). We recognize that this may have introduce systematic error. This error is assumed to be small in comparison to the large variation in measured responses. Respiratory system function measurements were obtained using a compliance testing instrument (Godart, Holland) and a pneumatoscope II (Jaeger, Germany).

The main factors of occupational exposure were internal alpha radiation due to inhalation of airborne 239Pu compounds and chronic total-body exposure to external gamma rays; 46.2% of examined workers started working at the Mayak PA before 1958 when annual gamma-ray doses were the highest due to imperfection of technological processes. Later, the improvements in the radiation environment led to a reduction in the annual gamma-ray exposures of workers (Koshurnikova et al. 1999; Vasilenko et al. 2000).

External gamma radiation doses (Dγ) to the total body were recorded by the dosimeter-control service of the Mayak PA, based on individual film badges. Dosimeter replacements and dose registrations were carried out once every month. After repair-maintenance work when the exposure risk was increased, dosimeter replacement and dose registration were carried out immediately. Before and during 1985, the dosimeter error was estimated to be about 60%. However, after 1985 this error was reduced to about 30%. The thermoluminescence method has been used since 1988 (Vasilenko et al. 2000).

The amount of incorporated 239Pu was estimated based on a urine bioassay carried out at the Biophysical Laboratory of the SUBI. The urine bioassay was based on the radiochemical method of double phosphate precipitation of 239Pu. The error in the estimated body burden of 239Pu was less than or equal to 30%. The detection limit for the 239Pu body burden was estimated to be 0.26 kBq (Russian Federal State Standard No. 37–2/93; Khokhryakov et al.2000a, b). Absorbed alpha radiation doses (Dα) to the lung were estimated based on the biokinetic model described by Khokhryakov et al. (2005). The model is a modification of the Human Respiratory Tract model (ICRP 1999). Total-body external gamma-ray doses and internal alpha radiation doses to the lung were calculated specifically for this respiratory function study.

Estimates of Dγ ranged from 0 to 3.82 Gy (average 0.44 ± 0.02 Gy). 239Pu body-burden estimates ranged from 0 to 91 kBq (average 2.65 ± 0.29 kBq), and Dα estimates ranged from 0 to 4.35 Gy (average 0.16 ± 0.1 Gy). The reported standard deviations relate to variability in dose estimates for different workers and does not include dose uncertainty. Addressing dose uncertainty was beyond the scope of our research project. Thus, dose estimates provided should be considered preliminary. The average age at the start of work at the Mayak PA was 23.7 ± 0.3 years for these workers.

Smoking information was obtained with the help of individual interviews which were held by medical staff during obligatory medical preventive examinations. Smoking intensity was characterized using the smoking index (SI), which was calculated as the product of the number of packs of cigarettes smoked per day (d) and number of years (y) of smoking, and it was evaluated up to the time of respiratory function measurement. Units for the SI are therefore packs*y/d. 82% of the examined Mayak workers were smokers, but 30% of these workers stopped smoking over the period that this study covers. Age at the start of smoking varied from 7 to 40 years (average 18.1 ± 0.3 y). On average, the duration of smoking was 26.5 ± 0.4 years at the time of follow-up. Some individuals smoked for more than 60 years. The average SI was 16.8 ± 0.4 packs*y/d and the maximum value of this index reached 61.3 packs*y/d. Morbidity information was based on medical documentation (case histories and medical cards).

Comparison of averages of study variables between smokers and non-smokers was based on Student’s t test and Kolmogorov-Smirnov test (Zar 1999). Multiple regression analysis was used (Draper and Smith 1981; Korn and Korn 1968) for estimation of covariate dependences on the basis of our empirical non-linear model. Statistical significance was based on p<0.05.

RESULTS AND DISCUSSION

Based on the well-known fact that smoking has a negative effect on respiratory function, results are shown separately for smokers and non-smokers (Table 1). Workers with smoking durations of greater than 1 year were classified as smokers. The remaining workers were classified as non-smokers. These groups did not differ significantly in the average age at the time of respiratory function measurement, average time from the start of work in radiation exposure conditions until the time of follow-up, or in average total-body external gamma-ray dose. Indices of respiratory function both for smokers and non-smokers were within the physiological normal range as described by the American Thoracic Society (1991). However, a consistent decrease of not only airway conductance (FEF1, FEF25, FEF50, FEF75) but also VC and DCO were observed as the SI increased (Table 1). Table 1 provides comparisons between smokers and nonsmokers based on group-specific averages of respiratory function measurements as well the percentage of predicted values. The largest difference between groups (15–17.6 %) was seen for FEF50 and FEF25 which characterize the functional states of middle and small bronchi. Differences in VC and DCO values between smokers and non-smokers didn’t exceed 3–4%. It was impossible to attribute unambiguously the decrease in indices of respiratory function to the effects of smoking because 239Pu body burdens and consequently Dα values were significantly higher for smokers than for non-smokers (Table 1).

TABLE 1.

Respiratory function data for male Mayak PA workers

Smokers
Nonsmokers
p for difference between
Index n avg. ± SE % pred. ± SE n avg. ± SE % pred. ± SE avg. % pred.
VC, L 937 4.5 ± 0.2 100.3 ± 0.3 261 4.6 ± 0.4 103.2 ± 0.7 0.0007 < 0.0001
FEV1, L/s 937 6.01 ± 0.03 96.9 ± 0.5 261 6.44 ± 0.06 100.6 ± 0.8 < 0.0001 < 0.0001
DCO, mL/min*mm Hg 153 16.4 ± 0.3 90.8 ± 1.7 47 17.9 ± 0.6 98.0 ± 3.0 0.02 0.04
FEF75 , L/s 88 6.9 ± 0.2 97.1 ± 2.9 30 7.8 ± 0.3 108.6 ± 3.4 0.01 0.033
FEF50 , L/s 88 3.7 ± 0.1 84.0 ± 2.9 30 4.4 ± 0.2 101.6 ± 5.1 0.007 0.003
FEF25 , L/s 88 1.4 ± 0.5 87.6 ± 2.9 30 1.7 ± 0.7 102.6 ± 4.8 0.0009 0.003
Absorbed alpha radiation dose to the lung, Gy 937 0.19 ± 0.01 261 0.10 ± 0.01 0.002
< 0. 001 b
Total body external gamma-radiation dose, Gy 937 0.46 ± 0.02 261 0.40 ± 0.03 0.196
>0.1 b
Smoking Index, packs*y/d 937 16.8 ± 0.4
Age at respiratory function measurement, y 937 44.4 ± 0.4 261 43.7 ± 0.8 0.406
Time from start of work to measurement, y 937 20.9 ± 0.3 261 20.8 ± 0.7 0.849
a

SE, standard error

b

p-value for olmogorov-Smirnov test

The following empirical threshold multifactor model was developed for the quantitative characterization of indices of respiratory functions under long-term exposure to alpha radiation from inhaled 239Pu aerosols and external gamma rays, taking into account the smoking history of nuclear workers at the Mayak PA:

Z=Z0ψln[II0+DαD0,α+DγD0,γ]+ɛ.

Z represents the specific index of respiratory function (expressed in %). Z0 is the mean value of indices of respiratory function in the reference group (controls), which was formed out of unirradiated non-smokers. Only one control group was used. It was comprised of non-smoking, non-irradiated individuals. Unfortunately, this group was very small (Table 2), but their average age at the time of respiratory function measurement (41.9 ± 1.8 y) and the average time from start of work to measurement (19.2 ± 1.7 y) were not significantly different (p > 0.1) from corresponding averages for the irradiated nonsmoker group in Table 1. The value for Z0 was fixed prior to our regression analysis. Thus, results were conditional on Z0. I and are I0 the smoking index and its threshold value (packs*y/d). D0,α is the threshold absorbed alpha radiation dose to the lung (Gy); D0,γ is the threshold external gamma-ray absorbed dose to the total body (Gy); ψ is the slope parameter. ɛ is the error term and has a mean of zero and variance of σ2 (presumed independent of SI and radiation doses Dα and Dγ ). The error term is needed to account for scatter in the real data. Based on our exploratory analysis of the data, Dγ was found to be negligible for the range of doses considered here and therefore has been excluded from subsequent equations.

TABLE 2.

Results of model parameters calculation of respiratory function

Model parameters
Index n % predicted value in reference group, Z0 ± SEa I0 ± SE D0 ± SE ψ
VC, % 41 101.58 ± 1.88 9.3 ± 1.8 0.39 ± 0.09 4.85
DCO , % 8 94.84 ± 6.37 9.0 ± 1.4 0.30 ± 0.07 6.99
FEF75, % 7 116.57 ± 5.83 8.6 ± 1.0 0.35 ± 0.10 31.32
FEF50, % 7 114.28 ± 8.67 4.0 ± 0.5 0.25 ± 0.11 25.44
FEF25, % 7 119.43 ± 8.35 2.9 ± 0.4 0.15 ± 0.07 20.10
a

SE, Standard error

Age has not been explicitly included as a covariate in our present model. Age-relate changes would be expected to have a similar influence on the numerator and denominator involved in assigning values to Z0 and Z so that the age influence would be expected to cancel. The duration of smoking and radiation exposure are accounted for via the exposure-time-dependent variables I, Dα , and Dγ. Systematic error in radiation doses (e.g., associated with dosimeter performance for gamma rays and bioassay for Pu incorporation) would be expected to cancel in application of Equation 1 since doses appear as ratios.

The following equation defines sub-threshold values when Dγ is negligible:

II0+DαD0,α<1.

Note that Equation 2 implicates an equivalence between smoking (I/I0) and alpha radiation (DαD0,α) induced damage to the respiratory system so far as the occurrence of respiratory dysfunction and the normalized functions I/I0 and D/D0. However, I0 and D0,α should not be considered to cause the same level and type of damage to the lung. The overall empirical threshold model is represented by the following equation:

Z={Z0+ɛ,ifII0+DαD0,α<1Z0ψln[II0+DαD0,α]+ɛ,ifII0+DαD0,α1

Geometric characteristics of the model (Equation 3) are shown in Figure 1. The following relationship was plotted (dashed contour line) to explain the meaning of ψ:

WhenII0+DαD0,α=e2.71,thenZ=Z0ψ.

FIG. 1.

FIG. 1.

Geometric interpretation of the mathematical model represented by Equation 3. The response variable Z is presented schematically as a function of covariates D (radiation absorbed dose) and I (smoking index). Corresponding radiation- and smoking-associated thresholds are given by D0 and I0, respectively. Z takes on the value Z0 ψ, when (I/I0) + (D/D0) = e (i.e., the base for natural logarithms).

Results of model applications to respiratory function measurements for chronically irradiated Mayak workers are shown in Table 2. The parameter ψ was subjectively changed while estimating I0 and D0 and therefore does not have an assigned standard error. The estimated thresholds I0 and D0 were statistically significant (p < 0.05). With our previous exploratory analysis with Dγ included, we were not able to detect a dependency of the respiratory function indices studied on Dγ. Also, no dependence of FEV1 on SI or Dα was found.

Figure 2 presents the dependence of FEF50 on Dα and SI. The indicated smooth response surface (sheet) is based on our model. Points falling above and below the model simulated surface are accounted for by the parameter ɛ when fitting the model to the data. Similar results were obtained for FEF25 and FEF 75 surfaces.

FIG 2.

FIG 2.

Response-surface characterization of the forced expiratory flow for 50% of forced vital capacity (FEF50%) as a function of the smoking index and absorbed alpha-radiation dose to the lung for chronically irradiated Mayak PA workers. The smooth surface is based on Equation 3. The data are ratios of observed to the predicted values. The evaluation of predicted values is explained in the text.

Figure 3 presents the dependence of VC on Dα and SI. The smooth response surface is based on our model. Points falling above and below the model simulated surface are accounted for by the parameter ɛ. Similar results were obtained for the FVC surface.

FIG 3.

FIG 3.

Response-surface characterization of the vital capacity (VC%) versus the smoking index and absorbed alpha-radiation dose to the lung for chronically irradiated Mayak workers. The smooth surface is based on Equation 3. The data are ratios of observed to the predicted values. The evaluation of predicted values is explained in the text.

The obtained data indicate significant decreases of airway conductance in smokers (based on FEV1, FEF25, FEF50, FEF75) and coincides with results of numerous studies which show a decrease in FEV1 under the influence of smoking (Sorlie et al. 1987; Xu et al. 1992; Sherrill et al. 1996). In our study we detected a decrease of FEF25 and FEF50, characteristic of reduced conductance of small and middle bronchi, which was more marked in comparison with other respiratory function indices. Similar results were obtained in a tobacco worker study (Mustajbegovic et al. 2003; Mukhtar et al. 1991). Tobacco smoke components have a direct damaging influence on bronchopulmonary tissue, initiate inflammatory processes accompanied with neutrophil and macrophage activation, affect the balance of proteolytic enzymes and antiprotease, and cause bronchial obstruction and oxidative stress leading to bronchi hypersensitivity (Willemse et al. 2004; Hunninghake and Crystal 1983; Pryor and Stone 1993; Zang et al. 1995; Wright et al. 1983). There are data showing development of diffuse interstitial pulmonary fibrosis in tobacco workers (Lorenzo 1988). Even short-term tobacco smoking causes an inflammatory response in bronchi mucous membranes (van der Vaart et al. 2005).

Application of the threshold multifactor regression model demonstrated a significant dependency between the respiratory function indices, SI and Dα, in Mayak nuclear workers. The study did not reveal a correlation between chronic exposure at low rates to gamma rays and the state of respiratory function. This is in agreement with previous studies (Belyaeva and Okladnikova 2003). It is worth mentioning that the average radiation doses for the workers studied were relatively small (average Dγ = 0.44 Gy, average Dα = 0.16 Gy). The indicated average doses were much lower than radiation doses reported to cause serious deterministic effects in the lung (Ilyin IA 2005; Okladnikova et al. 2000a,b; Muggenburg et al. 1988; Miller et al. 2003).

Alpha radiation threshold estimates for inducing respiratory system dysfunction ranged from 0.15 to 0.39 Gy depending on the respiratory function indices used. For deterministic effects in the lung an alpha radiation RBE of 12 has been recommended relative to gamma-ray exposure (Scott and Peterson 2003). This would indicate corresponding gamma-ray thresholds in the range 12*0.15 Gy-Equivalent (Eq) to 12*0.39 Gy-Eq or 1.8 to 4.7 Gy-Eq. The unit Gy-Eq applies to threshold-type deterministic effects rather than Sv (which apply to linear-no-threshold type responses) (IAEA 2005). In our exploratory analyses, we found no influence of gamma-ray doses up to 3.8 Gy (average dose of 0.44 Gy) on the respiratory system indices studied. This suggests that a higher RBE than 12 may apply for alpha radiation induced respiratory system dysfunction. More research is needed on this subject.

Threshold estimates provided should be considered preliminary as they were obtained on the basis of analyzing a relatively small number of respiratory function measurements for the examined Mayak workers. Future studies are required for improvements and would require new research support.

The multifactor model was used to address the combined effects of smoking and radiation on respiratory system functioning. The same approach might apply for evaluating respiratory system functioning after exposure to other airborne toxicants including complex mixtures.

CONCLUSIONS

  1. A new empirical mathematical model was introduced which allows quantitative characterizations of thresholds for smoking- and radiation-induced respiratory system dysfunction under circumstances of combined exposure. The model incorporates absolute thresholds for smoking- and radiation-induced dysfunction.

  2. The new model allows equating cigarette induced impairment with radiation induced impairment. Equal ratios I/I0 and Dα/D0,α reflect expected equal levels of respiratory system impairment for smoking and radiation. Similar relations could possibly be established for other pairs of respiratory system irritants using the same modeling approach.

  3. Respiratory function indices studied decreased as the alpha radiation dose to the lung increased from 0 to 4.36 Gy, while remaining in the normal range. The data were consistent with the view that alpha radiation doses to the lung above a relatively small threshold (0.15 to 0.39 Gy) cause respiratory system dysfunction.

  4. Respiratory function indices were not found to be influenced by total-body gamma radiation doses in the range 0–3.8 Gy when delivered at low rates over years.

  5. Significant decreases in airway conductance were shown in smokers when compared to non-smokers.

Acknowledgments

The authors would like to express their gratitude to O. Lifanova for translations and J. Di Palma for editorial assistance. This work was supported by the Office of Science (BER), U.S. Department of Energy, Grant Numbers DE-FG02-03ER63657 and DE-FGF02-03ER63671. Additional support for B. R. Scott was also provided by Lovelace Respiratory Research Institute.

REFERENCES

  1. Abratt RP, Morgan GW. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer. 2002;35(2):103–109. doi: 10.1016/s0169-5002(01)00334-8. [DOI] [PubMed] [Google Scholar]
  2. American Thoracic Society Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202–1218. doi: 10.1164/ajrccm/144.5.1202. [DOI] [PubMed] [Google Scholar]
  3. Anderson HR, Spix C, Medina S, Schouten JP, Castellsague J, Rossi G, Zmirou D, Touloumi G, Wojtyniak B, Ponka A, Bacharova L, Schwartz J, Katsouyanni K. Air pollution and daily admission for chronic obstructive pulmonary disease in 6 European cites: results from the APHEA project. Eur Respir J. 1997;10:1064–1071. doi: 10.1183/09031936.97.10051064. [DOI] [PubMed] [Google Scholar]
  4. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G. American Thoracic Society statement: occupation contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003;167:787–797. doi: 10.1164/rccm.167.5.787. [DOI] [PubMed] [Google Scholar]
  5. Belyaeva ZD, Okladnikova ND.2003Functional status of bronchopulmonary system among workers chronically irradiated in high doses Med. Radiology 48123–29.(in Russian) [Google Scholar]
  6. Draper NR, Smith H. Applied Regression Analysis. Second Edition. John Wiley and Sons; New York, USA: 1981. [Google Scholar]
  7. Gilbert ES, Koshurnikova NA, Sokolnikov ME, Khokhryakov VF, Miller S, Preston DL, Shilnikova NS, Suslova KG, Vostrotin VV. Liver cancers in Mayak workers. Radiat Res. 2001;154:246–252. doi: 10.1667/0033-7587(2000)154[0246:lcimw]2.0.co;2. [DOI] [PubMed] [Google Scholar]
  8. Hahn FF, Romanov SA, Guilmette RA, Nifatov AP, Zaytseva YV, Diel JH, Allen SW, Lyovkina YV. Distribution of plutonium particles in the lungs of Mayak workers. Radiat Prot Dosim. 2003;105(1–4):81–84. doi: 10.1093/oxfordjournals.rpd.a006326. [DOI] [PubMed] [Google Scholar]
  9. Higenbottam T, Clark TJ, Shipley MJ, Rose G. Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet. 1980;1:409–411. doi: 10.1016/s0140-6736(80)90955-1. [DOI] [PubMed] [Google Scholar]
  10. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis. 1983;1928:833–838. doi: 10.1164/arrd.1983.128.5.833. [DOI] [PubMed] [Google Scholar]
  11. International Atomic Energy Agency January2005Development of an Extended Framework for Emergency Response CriteriaInterim report for comments jointly sponsored by IAEA and WHO, Report IAEA-TECDOC-1432
  12. Ilyin IA.2005Plutonium Radiation Protection Pub At, Moscow; Russia: (in Russian) [Google Scholar]
  13. International Commission on Radiation Protection . Human Respiratory Tract Model for Radiobiological Protection. ICRP Publication 66. Oxford Press; Oxford, USA: 1999. [Google Scholar]
  14. Khokhryakov VF, Suslova KG, Filipy RE, Alldredge JR, Aladova EE, Glover SE, Vostrotin VV. Metabolism and dosimetry of actinide elements in occupationally exposed workers in Russia and the United States: a summary progress report. Health Phys. 2000a;79:63–71. doi: 10.1097/00004032-200007000-00011. [DOI] [PubMed] [Google Scholar]
  15. Khokhryakov VF, Suslova KG, Aladova EE, Vasilenko EK, Miller SC, Slaughter DM, Krahenbuhl MP. Development of an improved dosimetry system for the workers at the Mayak Production Association. Health Phys. 2000b;79:72–76. doi: 10.1097/00004032-200007000-00012. [DOI] [PubMed] [Google Scholar]
  16. Khokhryakov VF, Suslova KG, Vostrotin VV, Ronamov SA. Adaptation of the ICRP Publication 66 respiratory tract model to data on plutonium biokinetics for Mayak workers. Health Phys. 2005;88(2):125–132. doi: 10.1097/01.hp.0000144575.37546.9d. [DOI] [PubMed] [Google Scholar]
  17. Khokhryakov VV, Drozhko EG, Glagolenko YuV, Rovny SI, Vasilenko EK, Suslova AS, Anspaugh LR, Napier BA, Bouville A, Khokhryakov VF, Suslova KG, Romanov SA. Studies on the Ozyorsk population: dosimetry. Radiat Environ Biophys. 2002;41:33–35. doi: 10.1007/s00411-002-0147-6. [DOI] [PubMed] [Google Scholar]
  18. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Change in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1987;127:725–734. doi: 10.1164/arrd.1983.127.6.725. [DOI] [PubMed] [Google Scholar]
  19. Koo JW, Chung CK, Park CY, Lee S-H, Lee K-S, Roh Y-M, Yim JW. The effects of silica dust on ventilatory function of foundry workers. J Occup Health. 2000;42:251–257. [Google Scholar]
  20. Korn GA, Korn TM.1968Mathematical Handbook for Scientist and Engineers: Definitions, Theorems, and Formulas for Reference and Review 2nd edMcGraw-Hill; New York, USA: (Translated into Russian 1973. Nauka, Moscow, Russia) [Google Scholar]
  21. Koshurnikova NA, Aristov VP, Lemberg VK, Mushkacheva GS, Popliko MG, Tseveleva IA.1973Issue about pathogenesis of plutonium pneumofibrosis Archives of Pathology 448–54.(in Russian) [Google Scholar]
  22. Koshurnikova NA, Shilnikova NS, Okatenko PV, Kreslov VV, Bolotnokova MG, Sokolnikov ME, Khokhriakov VF, Suslova KG, Vasilenko EK, Romanov SA. Characteristics of the cohort of workers at the Mayak nuclear complex. Radiat Res. 1999;152(4):352–363. [PubMed] [Google Scholar]
  23. Lebowitz MD, Holberg CJ, Knudson RJ, Burrows B. Longitudinal study of pulmonary function development in childhood, adolescence, and early adulthood. Development of pulmonary function. Am Rev Respir Dis. 1987;136:69–75. doi: 10.1164/ajrccm/136.1.69. [DOI] [PubMed] [Google Scholar]
  24. Lorenzo R. Diffuse intersticial pulmonary fibrosis in tobacco-industry workers. Arsh Monaldi Mal Torace. 1988;43:235–241. [PubMed] [Google Scholar]
  25. Miller KL, Zhou SM, Barrier RC, Jr, Shafman T, Folz RJ, Clough RW, Marks LB. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2003;56(3):611–615. doi: 10.1016/s0360-3016(03)00182-2. [DOI] [PubMed] [Google Scholar]
  26. Muggenburg BA, Guilmette RA, Mewhinney JA, Gillet NA, Mauderly JL, Griffits WC, Scott BR, Hahn FF, Boecker BB. Toxicity of inhaled plutonium dioxide in beagle dogs. Radiat Res. 1996;145(3):361–381. [PubMed] [Google Scholar]
  27. Muggenburg BA, Wolff RK, Maudery JL, Plaggmier MM, Hahn FF, Guilmette RA, Gerlach RF. Cardiopylmonary function of dogs with plutonium-induced chronic lung injury. Radiat Res. 1988;115(2):314–324. [PubMed] [Google Scholar]
  28. Mukhtar MS, Rao GM, Gamra NS, Afan AM, Zenden MI. Respiratory effects of occupational exposure to tobacco dust. Respiration. 1991;58:271–276. doi: 10.1159/000195944. [DOI] [PubMed] [Google Scholar]
  29. Mustajbegovic J, Zuskin E, Schachter EN, Kern J, Luburic-Milas M, Pucarin J. Respiratory Findings in Tobacco Workers. Chest. 2003;123:1740–1748. doi: 10.1378/chest.123.5.1740. [DOI] [PubMed] [Google Scholar]
  30. Okladnikova ND, Kudryavtseva TI, Belyaeva ZD.2000aProfessional (plutonium) pulmonary fibrosis among first atomic enterprise workers (results of 40-years follow-up) Issues of Radiation Safety 142–49.(in Russian). [Google Scholar]
  31. Okladnikova ND, Kudryavtseva TI, Beliaeva ZD.2000(b)Plutonium pneumosclerosis: Results of long-term medical observation Issue of Radiation Safety 42–49.(in Russian) [Google Scholar]
  32. Okladnikova ND, Pesternikova VS, Azizova TV, Sumina MV, Kabasheva NY, Belyaeva ZD, Fevralev AM.2000cHealth status of the personnel of processing waste nuclear fuel plant Occupational Medicine and Industrial Ecology 610–14.(in Russian) [Google Scholar]
  33. Pryor WA, Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxides, peroxynitrate and peroxynitrite. Ann NY Acad Sci. 1993;686:12–28. doi: 10.1111/j.1749-6632.1993.tb39148.x. [DOI] [PubMed] [Google Scholar]
  34. Russian Fed State Stand No. 37-2/93 1993. Plutonium. Express method for double phosphate co-precipitation from urine specimens. Saint Petersburg: General State Center for Measurement Standards, Mendeleev NPO VNIM (in Russian).
  35. Samet JM, Lange P. Longitudinal studies of active and passive smoking. Am J Respir Crit Care Med. 1996;154:S257–S265. doi: 10.1164/ajrccm/154.6_Pt_2.S257. [DOI] [PubMed] [Google Scholar]
  36. Scott BR, Peterson VL. Risk estimates for deterministic health effects of inhaled weapons grade plutonium. Health Physics. 2003;85(3):280–293. doi: 10.1097/00004032-200309000-00005. [DOI] [PubMed] [Google Scholar]
  37. Sherrill DL, Enright P, Cline M, Burrous B, Lebowitz MD. Rates of decline in lung function among subject who restart cigarette smoking. Chest. 1996;109:1001–1005. doi: 10.1378/chest.109.4.1001. [DOI] [PubMed] [Google Scholar]
  38. Shilnikova NS, Preston DL, Ron E, Gilbert ES, Vasilenko EK, Romanov SA, Kuznetsova IS, Sokolnikov ME, Okatenko PV, Kreslov VV, Koshurnikova NA. Cancer mortality risk among workers at the Mayak Nuclear Complex. Radiat Res. 2003;159:787–798. doi: 10.1667/0033-7587(2003)159[0787:cmrawa]2.0.co;2. [DOI] [PubMed] [Google Scholar]
  39. Sorlie P, Lakatos E, Kannel WB, Celli B. Influence of cigarette smoking on lung function at baseline and at follow-up in 14 years: the Framingham Study. J Chronic Dis. 1987;40:849–856. doi: 10.1016/0021-9681(87)90184-6. [DOI] [PubMed] [Google Scholar]
  40. Suslova KG, Khokhryakov VF, Tokarskaya ZB, Nifatov AP, Krahenbuhl MP, Miller SC. Extrapulmonary organ distribution of plutonium in healthy workers exposed by chronic inhalation at the Mayak Production Association. Health Phys. 2002;82:432–444. doi: 10.1097/00004032-200204000-00002. [DOI] [PubMed] [Google Scholar]
  41. Thomas O, Mahe M, Campion L, Bourdin S, Milpied N, Brunet G, Lisbona A, Le Mevel A, Moreau P, Harousseau J, Cuilliere J. Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys. 2001;49(1):125–131. doi: 10.1016/s0360-3016(00)01373-0. [DOI] [PubMed] [Google Scholar]
  42. Tokarskaya ZB, Okladnikova ND, Belyaeva ZD, Drozhko EG. The influence of radiation and non-radiation factors on the lung cancer incidence in Mayak workers. Health Phys. 1995;69:356–366. doi: 10.1097/00004032-199509000-00007. [DOI] [PubMed] [Google Scholar]
  43. Tokarskaya ZB, Zhuntova GV, Scott BR, Khokhryakov VF, Belyaeva ZD, Vasilenko EK, Syrchikov VA. Influence of alpha and gamma radiations and non-radiation risk factors on the incidence of malignant liver tumors among Mayak PA workers. Health Phys. 2006;91(4):296–310. doi: 10.1097/01.HP.0000215840.24538.8b. [DOI] [PubMed] [Google Scholar]
  44. van der Vaart H, Postma DS, Timens W, Hylkema MN, Willemse BW, Boezen HM, Vonk JM, de Reus DM, Kauffman HF, ten Hacken NH. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res. 2005;6(1):22. doi: 10.1186/1465-9921-6-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Vasilenko EK, Miller S, Jakob P.2000Individual dosimetry of external occupational exposure of Mayak workers Issues Radiat Safety 1852–58.(in Russian). [Google Scholar]
  46. Willemse BWM, Postma DS, Timens W, ten Hacken NHT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23:464–476. doi: 10.1183/09031936.04.00012704. [DOI] [PubMed] [Google Scholar]
  47. Wright JL, Lawson LM, Pare PD, Kennedy S, Wiggs B, Hogg JC. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis. 1983;127:474–477. doi: 10.1164/arrd.1983.127.4.474. [DOI] [PubMed] [Google Scholar]
  48. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG., Jr Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis. 1992;146:1345–1348. doi: 10.1164/ajrccm/146.5_Pt_1.1345. [DOI] [PubMed] [Google Scholar]
  49. Zang LY, Stone K, Pryor WA. Detection of free radicals in aqueous extracts of cigarette tar by electrospin resonance. Free Radic Biol Med. 1995;19:161–167. doi: 10.1016/0891-5849(94)00236-d. [DOI] [PubMed] [Google Scholar]
  50. Zar JH. Biostatistical analysis. 4th ed. Prentice Hall; New Jersey, USA: 1999. [Google Scholar]

Articles from Dose-Response are provided here courtesy of SAGE Publications

RESOURCES